88 related articles for article (PubMed ID: 16827129)
1. Alteration of gene expression in melanoma cells following combined treatment with E2F-1 and doxorubicin.
Hao H; Dong YB; Bowling MT; Zhou HS; McMasters KM
Anticancer Res; 2006; 26(3A):1947-56. PubMed ID: 16827129
[TBL] [Abstract][Full Text] [Related]
2. E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.
Dong YB; Yang HL; McMasters KM
Cancer Gene Ther; 2003 Mar; 10(3):168-78. PubMed ID: 12637937
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
4. Chemosensitization of tumor cells: inactivation of nuclear factor-kappa B associated with chemosensitivity in melanoma cells after combination treatment with E2F-1 and doxorubicin.
Hao H; Zhou HS; McMasters KM
Methods Mol Biol; 2009; 542():301-13. PubMed ID: 19565909
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis signal-regulating Kinase 1 by E2F-1 may not be essential for E2F-1-mediated apoptosis in melanoma cells.
Dong YB; Phelps AM; Yang HL; Jamshidi-Parsian A; Chen C; Hao H; Gomez-Gutierrez JG; Zhou HS; McMasters KM
Tumour Biol; 2007; 28(2):111-22. PubMed ID: 17287612
[TBL] [Abstract][Full Text] [Related]
6. Microarray-analysis: a new approach to study the molecular mechanisms of thermo-chemotherapy.
Schulte JH; Schramm A; Pressel T; Klein-Hitpass L; Kremens B; Eils J; Havers W; Eggert A
Klin Padiatr; 2003; 215(6):298-302. PubMed ID: 14677092
[TBL] [Abstract][Full Text] [Related]
7. E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas.
De Meyer T; Bijsmans IT; Van de Vijver KK; Bekaert S; Oosting J; Van Criekinge W; van Engeland M; Sieben NL
J Pathol; 2009 Jan; 217(1):14-20. PubMed ID: 18991331
[TBL] [Abstract][Full Text] [Related]
8. Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma.
Liu F; Wang P; Jiang X; Tan G; Qiao H; Jiang H; Krissansen GW; Sun X
Cancer Sci; 2008 Oct; 99(10):2055-61. PubMed ID: 19016766
[TBL] [Abstract][Full Text] [Related]
9. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
10. Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma.
Roh V; Laemmle A; Von Holzen U; Stroka D; Dufour JF; Hunt KK; Candinas D; Vorburger SA
Cancer Gene Ther; 2008 Oct; 15(10):636-44. PubMed ID: 18535617
[TBL] [Abstract][Full Text] [Related]
11. Effects of emodin on gene expression profile in small cell lung cancer NCI-H446 cells.
Fu ZY; Han JX; Huang HY
Chin Med J (Engl); 2007 Oct; 120(19):1710-5. PubMed ID: 17935676
[TBL] [Abstract][Full Text] [Related]
12. Low concentrations of doxorubicin sensitizes human solid cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-receptor (R) 2-mediated apoptosis by inducing TRAIL-R2 expression.
Wu XX; Jin XH; Zeng Y; El Hamed AM; Kakehi Y
Cancer Sci; 2007 Dec; 98(12):1969-76. PubMed ID: 17922852
[TBL] [Abstract][Full Text] [Related]
13. Monitoring the gene expression profiles of doxorubicin-resistant acute myelocytic leukemia cells by DNA microarray analysis.
Song JH; Choi CH; Yeom HJ; Hwang SY; Kim TS
Life Sci; 2006 Jun; 79(2):193-202. PubMed ID: 16458935
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional culture of melanoma cells profoundly affects gene expression profile: a high density oligonucleotide array study.
Ghosh S; Spagnoli GC; Martin I; Ploegert S; Demougin P; Heberer M; Reschner A
J Cell Physiol; 2005 Aug; 204(2):522-31. PubMed ID: 15744745
[TBL] [Abstract][Full Text] [Related]
15. cDNA microarray study to identify expression changes relevant for apoptosis in K562 cells co-treated with amifostine and imatinib.
Bianchini M; Martinelli G; Renzulli M; Gonzalez Cid M; Larripa I
Cancer Chemother Pharmacol; 2007 Feb; 59(3):349-60. PubMed ID: 17009037
[TBL] [Abstract][Full Text] [Related]
16. Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines.
Stravopodis DJ; Karkoulis PK; Konstantakou EG; Melachroinou S; Lampidonis AD; Anastasiou D; Kachrilas S; Messini-Nikolaki N; Papassideri IS; Aravantinos G; Margaritis LH; Voutsinas GE
Int J Oncol; 2009 Jan; 34(1):137-60. PubMed ID: 19082486
[TBL] [Abstract][Full Text] [Related]
17. [Construction of a eukaryotic vector expressing E2F-1 Gene and its effect on proliferation of gastric cancer cell line MKN-45].
Wang CQ; Xiao Q; Li L; Xie YB; Tan N; Gong ZW
Ai Zheng; 2007 Oct; 26(10):1064-8. PubMed ID: 17927874
[TBL] [Abstract][Full Text] [Related]
18. Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance.
Veitch ZW; Guo B; Hembruff SL; Bewick AJ; Heibein AD; Eng J; Cull S; Maclean DA; Parissenti AM
Pharmacogenet Genomics; 2009 Jun; 19(6):477-88. PubMed ID: 19440163
[TBL] [Abstract][Full Text] [Related]
19. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional analysis of doxorubicin-induced cytotoxicity and resistance in human hepatocellular carcinoma cell lines.
Wang J; Chan JY; Fong CC; Tzang CH; Fung KP; Yang M
Liver Int; 2009 Oct; 29(9):1338-47. PubMed ID: 19627484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]